Skip to content
Review Open access

Endocrino-Immuno-Senescence and Its Correlation with Age-Related Diseases: Molecular Insights into Immunomodulatory Strategies for Healthy Aging.

Aug 2026 · Aging and Disease · 0 citations
Medicine

TL;DR

A comprehensive understanding of the mechanisms by which endocrino-immuno-senescence is coordinately associated with a variety of pathological processes is provided and new insights into immunomodulatory strategies ameliorating age-related diseases for healthy aging and quality living are delineated.

Abstract

Regulation of the endocrine and immune system is pivotal for bodily homeostasis and healthy physiology, and these processes deteriorate as life progresses from adulthood to senescence. Aging, progressively weakening the structural and functional efficacies of the hypothalamic-pituitary-thyroid-adrenal-gonadal autoregulating axis, results in endocrino-immuno-senescence (EIS) that modulates a variety of complications and diseases. Both endocrine and immune responses are compromised during aging, along with impaired tissue regeneration, weakened pathogen detection, and decreased immune surveillance, and these events increase the susceptibility to infection, autoimmunity, cancers, and chronic disorders. Nonetheless, while immunosenescence modulates systemic inflammation and overall host defense, inflammaging accelerates tissue deterioration and intensifies diverse pathologies. Dysregulation of hormonal, genetic, and epigenetic machineries dampens the immune system, elevates pro-inflammatory activity, and fails to defend an organism against foreign pathogens, representing a link between cellular dysfunction and EIS. To mitigate these events, immunomodulation is an important therapeutic strategy that helps renew endocrine and immune dysregulation and simultaneously diminish age health disparities. Moreover, preservation of hormonal stability, involving immune response, emerges as a central determinant and could serve as a preventive medicine for the health and well-being of aged populations. This review provides a comprehensive understanding of the mechanisms by which EIS is coordinately associated with a variety of pathological processes and delineates new insights into immunomodulatory strategies ameliorating age-related diseases for healthy aging and quality living.

Read PDF

Similar papers

Review Aug 2026

The Intersection of Immunosenescence, Cellular Senescence, and Type 1 Diabetes: Paving the Way for Future Interventions.

It is proposed that T1D may induce a state of premature immunosenescence, even in relatively young individuals, which may further exacerbate autoimmunity, creating a self-reinforcing cycle between autoimmunity and immune aging mechanisms.

D. Saavedra, Rahul Mittal, C. Blaschke et al. · 0 citations
Review Aug 2026

The senescence-immune axis as a target for combining immunotherapy and senotherapy.

This review focuses on the molecular and cellular mechanisms through which SnCs modulate immune composition and function, emphasizing immune checkpoint ligands, stress-associated surface molecules, and senescence-associated transcriptional programs governing senescence-associated secretory phenotype (SASP) expression.

Fernanda Saez-Calazans, L. Grun, Lucas Emanuel Stein et al. · 0 citations
Review Open access Sep 2026

Immune checkpoints and immunoregulation in metabolic diseases and cancers: pathological mechanisms and therapeutic potential

This review comprehensively elucidates the pathophysiological mechanisms and translational potential of immune checkpoint regulation in obesity, diabetes, and thyroid disease while proposing novel directions for clinical intervention.

Min-Min Xiang, Shuang Liu, De-Sheng Xiao et al. · 1 citation
Review Open access Sep 2026

Immunosenescence, inflammaging, and metabolic disease: A geroscience perspective on mechanisms and links.

The immunometabolic interface provides a useful geroscience framework for understanding aging-related metabolic disease, although the direction, reversibility, and modifiability of these relationships in humans remain incompletely resolved.

Zi-Yu Ye, Le-Hua Yu, Zi-Ran Li et al. · 0 citations
Review Open access Sep 2026

Brain Aging and Cellular Senescence Trigger Neuroimmunological Dysregulation and Neurodegeneration

D dysfunction in bidirectional communication pathways between the immune system and the central nervous system, driven by immunosenescence in neural cells, including glial cells and neurons, which are postmitotic cells that can acquire phenotypic traits associated with senescence, facilitates SASP activation, leading t...

Vega-García Angélica, Manuel-Apolinar Leticia, Feria-Romero Iris Angélica et al. · 0 citations
Review Open access Aug 2026

The Gut–Immune–Brain Axis in Aging: Integrating Immunosenescence, Inflammaging, and Neuroinflammation for Precision Medicine

Prioritizing functional resilience over microbial taxonomy may improve biomarker discovery, patient stratification, and microbiome-targeted interventions for neurodegenerative disease prevention for neurodegenerative disease prevention.

D. Bajić, Jelena Vučković, Nikolina Pupovac et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.